
Actinic keratosis is a chronic skin disease and one of the most common diagnoses in dermatology practices in Europe

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica

Around 112,000 new cases of skin cancer will be diagnosed in the US in 2026

The mRNA-based therapy, used with Keytruda, is designed specifically for each patient

The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe

The treatment is for cerebral adrenoleukodystrophy, a rare neurodegenerative disease

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood

Globally, around 150 to 200 out of every million people have myasthenia gravis

The EU body underlines its commitment to diverse perspectives in medicines regulation

Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer

The scheme supports the development of treatments targeting unmet medical needs in the EU